HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
NEWSROOM
CONTACT
More
4BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A
4BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science